These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10405232)

  • 1. Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
    Mera R; Realpe JL; Bravo LE; DeLany JP; Correa P
    J Clin Gastroenterol; 1999 Jul; 29(1):51-5. PubMed ID: 10405232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
    Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
    Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
    Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
    Dubois A; Berg DE; Fiala N; Heman-Ackah LM; Perez-Perez GI; Blaser MJ
    J Gastroenterol; 1998 Feb; 33(1):18-22. PubMed ID: 9497216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
    Graham DY; Hoffman J; el-Zimaity HM; Graham DP; Osato M
    Aliment Pharmacol Ther; 1997 Oct; 11(5):935-8. PubMed ID: 9354203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
    Harford W; Lanza F; Arora A; Graham D; Haber M; Weissfeld A; Rose P; Siepman N
    Helicobacter; 1996 Dec; 1(4):243-50. PubMed ID: 9398875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients.
    Kearney DJ; Brousal A
    Dig Dis Sci; 2000 Feb; 45(2):265-71. PubMed ID: 10711436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
    Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
    Pilotto A; Franceschi M; Leandro G; Bozzola L; Fortunato A; Rassu M; Meli S; Soffiati G; Scagnelli M; Di Mario F; Valerio G
    J Gastroenterol Hepatol; 1999 May; 14(5):468-75. PubMed ID: 10355512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
    Zhang W; Chen Q; Liang X; Liu W; Xiao S; Graham DY; Lu H
    Gut; 2015 Nov; 64(11):1715-20. PubMed ID: 26338726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
    Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
    Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: a short report.
    Riff DS; Kidd S; Rose P; Haber M; Weissfeld A; Siepman N
    Helicobacter; 1996 Dec; 1(4):238-42. PubMed ID: 9398874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.
    Perri F; Festa V; Merla A; Quitadamo M; Clemente R; Andriulli A
    Helicobacter; 2002 Apr; 7(2):99-104. PubMed ID: 11966868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin.
    Cammarota G; Tursi A; Papa A; Montalto M; Veneto G; Cuoco L; Fedeli G; Gasbarrini G
    Aliment Pharmacol Ther; 1996 Dec; 10(6):997-1000. PubMed ID: 8971300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.